摘要：There is evidence from the empirical sciences that ‘happiness’ – understood in the social scientists’ sense of ‘positive affect’– leads to prosocial behaviour: the happiest amongst us are more likely to help others. There is also scientific evidence of a genetic component to positive affect: genetic differences can account for some of the observed variances in positive affect. Let us think of ‘happy-people-pills’ as pharmacological agents, modeled on those with a genetic predisposition for high levels of positive affect, which will promote positive moods and emotions in ‘normally’ happy persons. It is argued that if we want to increase prosocial behaviour then we should (other things being equal) promote the use of happy-people-pills. Since we should inc rease prosocial behaviour, we should (other things being equal) promote the use of happy-people-pills. In a short paper like this, I cannot possibly show that everything else is equal. However, I hope to establish at least a prima facie case for policy that permits the creation and distribution of happy-people-pills.
